6533b85ffe1ef96bd12c113b
RESEARCH PRODUCT
Estradiol reduces F2α-isoprostane production in cultured human endothelial cells
María Cinta García-martínezAntonio CanoCarlos EhermenegildoJuan J. Tarínsubject
MaleUmbilical Veinsmedicine.medical_specialtyAntioxidantIsoprostaneEndotheliumPhysiologymedicine.drug_classmedicine.medical_treatmentMedroxyprogesterone AcetateIsoprostanesBiologymedicine.disease_causeUmbilical veinchemistry.chemical_compoundPiperidinesPhysiology (medical)Internal medicinemedicineHumansFulvestrantCells CulturedProgesteroneDose-Response Relationship DrugEstradiolProgesterone CongenersEstrogen AntagonistsInfant NewbornEndothelial stem cellEndocrinologymedicine.anatomical_structurechemistryCell cultureEstrogenCulture Media ConditionedFemaleEndothelium VascularCardiology and Cardiovascular Medicinehormones hormone substitutes and hormone antagonistsOxidative stressdescription
Free radical-generated F2α-isoprostanes are a group of compounds with vasoconstrictor properties. To investigate whether estradiol exerts antioxidant actions modifying F2α-isoprostane production, cultured human umbilical vein endothelial cells were exposed to estradiol and other compounds and F2α-isoprostanes were measured in culture medium. Exposure to 1 and 10 nM estradiol for 24 h reduced F2α-isoprostane production by 36 and 49%, respectively ( P < 0.001 vs. control). Exposure to antiestrogens alone (ICI-182780 or EM-652) slightly reduced F2α-isoprostanes ( P < 0.05 vs. control), but much less than exposure to estradiol ( P < 0.05). ICI-182780 reversed the estradiol-induced reduction of F2α-isoprostane concentration ( P < 0.05). Along with time-course analysis, these results suggest that estradiol effects were mediated through estrogen receptor-dependent and -independent mechanisms. Progestogens alone (progesterone or medroxyprogesterone acetate) did not modify F2α-isoprostane production at any of the tested concentrations (1, 10, and 100 nM). Progesterone completely reversed estradiol-induced reduction of F2α-isoprostane production ( P < 0.05 vs. control and estradiol), but medroxyprogesterone acetate did not ( P < 0.05 vs. control).
year | journal | country | edition | language |
---|---|---|---|---|
2002-12-01 | American Journal of Physiology-Heart and Circulatory Physiology |